Photophysical characterization of cinnamates.

The photophysical properties of five methoxy-substituted 2-ethylhexylcinnamates were studied with experimental and theoretical methods. It was found that the fluorescence quantum yields varied strongly with the substitution pattern of the phenyl ring. A methoxy substitution at the meta position gave strong fluorescence, whereas the para substituted compounds were strongly quenched. This observation could be correlated to corresponding changes in the UV absorption spectra; the two lowest pipi* states were split for the meta-methoxy substituted cinnamate but almost degenerate for the para compound. Semi-empirical quantum mechanical calculations confirmed both the observed state order and the difference in the experimentally determined activation energies for non-radiative decay. This "meta-effect" was also preserved in the trimethoxy-substituted compounds, 2-ethylhexyl-2,4,5- and 2,4,6-trimethoxycinnamate, resulting in strong fluorescence and relatively high barrier for non-radiative decay in the former and weak fluorescence and relatively low barrier for non-radiative decay in the latter. The obtained information shows how the performance of the commercial sunscreen agent, 2-ethylhexyl-para-methoxycinnamate (OMC) might be improved.

Cytotoxicity, acute oral toxicity, and skin irritation of 2-ethylhexyl-2,4,5-trimethoxycinnamate and di(2-ethylhexyl)-2,4,5-trimethoxybenzalmalonate.

Safety of two new ultraviolet (UV) filters, 2-ethylhexyl-2,4,5-trimethoxycinnamate (E8) and 2-ethylhexyl-2,4,5-trimethoxybenzalmalonate (B8), has been evaluated through the human melanoma cytotoxicity test and seven-day acute oral toxicity studies in rats. At 2.5 mg/mL, both compounds gave similar cell viability to the control. LD50 values for E8 and B8 are more than 5000 and 1000 mg/kg body weight, respectively. No significant difference in body weight and hematological parameters among the 0, 5, 50, 500, and 5000 mg/Kg E8-treated animals could be detected. Pathological examination of rat tissues collected at the end of the study period revealed no significant difference between the control and all E8-administered rats. There was no significant difference in all clinical blood chemistry parameters (aspartate aminotransferase, creatinine, blood urea nitrogen, and cholesterol), except alanine aminotransferase (ALT), between the control and the E8-treated animals. All ALT values were, however, in the normal range of SD rats. E8 showed negative results for the skin irritation study on human volunteers, using patch and photopatch tests. Excitation of respiratory signs of dypsnea in 10, 100, and 1000 mg/Kg B8-treated rats could be observed during 1-24 h. All groups were, however, normal during the second to the seventh day. Hematological parameters of the 0, 10, 100, and 1000 mg/Kg B8-treated animals showed no significant difference. Pathological examination revealed no significant difference between the control and all B8-administered rats. However, significant differences in some clinical blood chemistry parameters and body weights between the control and some B8-treated animals could be detected. All values, however, were in the normal ranges of the SD rats.